Hualan Biological Engineering proposes significant mid-year cash dividend

Hualan Biological Engineering announced its preliminary profit distribution plan for the first half of 2025, proposing a cash dividend of CNY 5 per 10 shares based on a total share capital of 1,827,456,666 shares. This totals CNY 913,728,333.00, representing 177.13% of the net profit attributable to listed company shareholders in the consolidated report for the first half of 2025. The proposal aligns with the company’s long-term shareholder return strategy and remains subject to approval at the second extraordinary general meeting in 2025.

The decision is supported by the company’s strong financial health, with an unaudited consolidated undistributed profit of CNY 7,885,280,035.22 and a parent company undistributed profit of CNY 2,761,106,442.53 as of June 30, 2025. The board emphasized that the plan considers future business development and capital needs, ensuring it will not adversely affect the company's normal operations or sustained growth.

This distribution follows a comprehensive review of the company's financial results for the first half of 2025, which also included the approval of its semi-annual report. Hualan Biological Engineering aims to enhance investor confidence and optimize its capital structure, given its robust cash flow from operating activities of CNY 230,506,958.78 and high currency funds and transactional financial assets amounting to CNY 7.69 billion.